Literature DB >> 20848912

Specifically activated dendritic cells--cell-based vaccine against lymphosarcoma exhibiting multiple drug resistance phenotype.

N L Mironova1, E E Panzinskyi, N A Popova, V P Nikolin, M A Zenkova, V V Vlasov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20848912     DOI： 10.1134/s1607672909050081

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  13 in total

1.  Dendritic cells: at the clinical crossroads.

Authors:  J J Mulé
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 2.  Dendritic cells: immune regulators in health and disease.

Authors:  Mary F Lipscomb; Barbara J Masten
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

3.  Dendritic cell-based vaccines in patients with hematological malignancies.

Authors:  W Brugger; A Schneider; T Schammann; P Dill; F Grünebach; H J Bühring; L Kanz; P Brossart
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

Review 4.  Dendritic cells: a journey from laboratory to clinic.

Authors:  Vincenzo Cerundolo; Ian F Hermans; Mariolina Salio
Journal:  Nat Immunol       Date:  2004-01       Impact factor: 25.606

Review 5.  Dendritic cell immunotherapy: mapping the way.

Authors:  Carl G Figdor; I Jolanda M de Vries; W Joost Lesterhuis; Cornelis J M Melief
Journal:  Nat Med       Date:  2004-05       Impact factor: 53.440

6.  Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.

Authors:  Fabio Morandi; Sabrina Chiesa; Paola Bocca; Enrico Millo; Annalisa Salis; Massimo Solari; Vito Pistoia; Ignazia Prigione
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

Review 7.  Physiology and pathophysiology of dendritic cells.

Authors:  V Wright-Browne; K L McClain; M Talpaz; N Ordonez; Z Estrov
Journal:  Hum Pathol       Date:  1997-05       Impact factor: 3.466

8.  Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma.

Authors:  R Lau; F Wang; G Jeffery; V Marty; J Kuniyoshi; E Bade; M E Ryback; J Weber
Journal:  J Immunother       Date:  2001 Jan-Feb       Impact factor: 4.456

Review 9.  Tumour escape from immune surveillance through dendritic cell inactivation.

Authors:  Alain P Vicari; Christophe Caux; Giorgio Trinchieri
Journal:  Semin Cancer Biol       Date:  2002-02       Impact factor: 15.707

Review 10.  Dendritic cell biology and cancer therapy.

Authors:  Theresa L Whiteside; Christine Odoux
Journal:  Cancer Immunol Immunother       Date:  2003-12-18       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.